Further studies are warranted to elucidate the transcriptional regulation of TIMP3 by HIF-1α and to validate its role in vivo, which may contribute to the advancement of targeted therapeutic strategies for bladder cancer. The gene discussed is TIMP3; the disease is urinary bladder carcinoma.